HOLX Stock Recent News
HOLX LATEST HEADLINES
MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #HGWHI--72 Million American Women Have Skipped or Delayed Vital Screenings.
Hologic (HOLX) concluded the recent trading session at $74.53, signifying a +0.58% move from its prior day's close.
Hologic's (HOLX) fundamental strength and cheaper valuation make it a great new addition to the portfolio.
Deteriorating geopolitical situation and supply bottlenecks mar the prospects of the Zacks Medical Instruments industry. Yet, HOLX, MASI and VCYT are worth buying based on strategic developments and fundamentals.
Stephens initiated coverage on Hologic Inc HOLX, citing it as a major player in women's health, known for its consistent revenue growth, strong free cash flow, and attractive profit margins, is well-positioned in the molecular diagnostics sector post-COVID.
Hologic (HOLX) closed at $71.65 in the latest trading session, marking a -1.15% move from the prior day.
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.
Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Investing in beaten-down stocks like OPCH, LNTH and HOLX can be profitable for investors in the long term.